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Abstract The cytochrome bd quinol oxidase is a component of
the respiratory chain of many prokaryotes. The enzyme contains
two subunits, CydA and CydB, which were initially predicted
based on the sequence of the Escherichia coli oxidase to have
seven and eight transmembrane spans, respectively. More re-
cently, the topological model of CydA was revised to predict
nine transmembrane helices, based on additional sequence infor-
mation from other organisms. In the current work, the topology
of the E. coli oxidase was experimentally examined using L-
lactamase gene fusions. The results con¢rm the revised topolo-
gy, which places the oxygen reactive site near the periplasmic
surface.
$ 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The cytochrome bd quinol oxidase is a component of the
respiratory chains of many prokaryotes [1^3] and is often
associated with growth under conditions of low aeration.
Most prokaryotic quinol oxidases and cytochrome c oxidases
belong to the heme-copper oxidase superfamily [4,5], but cy-
tochrome bd is not part of this superfamily [1,3,6]. Mutations
of cytochrome bd in both Shigella £exneri [7] and in Brucella
abortus [8] result in decreased virulence, and the enzyme may
play a role in protection against oxidative stress [9]. Since this
oxidase is found only in bacteria, including a number of hu-
man pathogens, cytochrome bd may be of interest as a drug
target.
The most extensively characterized cytochrome bd is the
one isolated from Escherichia coli [6,10^13], where it is ex-
pressed maximally under microaerophilic growth conditions
[14,15]. The enzyme consists of one copy each of two integral
membrane subunits, CydA (subunit I) and CydB (subunit II),
encoded by the cydAB operon in E. coli [16,17]. The enzyme
catalyzes the two-electron oxidation of ubiquinol-8 or mena-
quinol-8 in the bacterial membrane, and the four-electron
reduction of dioxygen to water. The quinol oxidation results
in the release of protons to the periplasm and the generation
of a proton motive force [13,18^20]. The proton motive force
results from the fact that the electrons and protons used in the
chemistry of converting O2 to water are delivered to the active
site from opposite sides of the membrane.
The enzyme contains three heme prosthetic groups: heme
b558, heme b595 and heme d. Heme b558 has been implicated in
the oxidation of ubiquinol, and the axial ligands have been
identi¢ed as His186 [21] and Met393 [22] in subunit I. In both
the initially proposed and revised topologies of subunit I,
these residues are predicted to be near the periplasmic end
of transmembrane helices [3,23]. The proposed locations of
these residues are shown in the models depicted in Fig. 1A
and B.
The active site where O2 is reduced to water is a bimetallic
center comprised of heme b595 and heme d [12,24,25]. O2 binds
to the ferrous iron of heme d [1,26,27], and the role of heme
b595 [10] is not known. The axial ligand of heme b595 has been
identi¢ed as His19 in subunit I [21,28]. According to the ini-
tially proposed topology of subunit I [23,29], this residue was
predicted to be near the cytoplasmic side of the bacterial
membrane (Fig. 1A), but the revised topology [3] places
His19 near the periplasmic surface (Fig. 1B). According to
the initially proposed topology (Fig. 1A), the major charge
movement responsible for the generation of a transmembrane
potential during turnover of cytochrome bd is electron trans-
fer from heme b558 near the outer surface of the membrane to
the heme b595/heme d active site on the opposite side of the
membrane (see Fig. 2B). In contrast, if His19 (i.e. heme b595
and heme d) is located near the periplasmic surface, then the
membrane potential must result primarily from protons mov-
ing from the bacterial cytoplasm to the enzyme active site on
the opposite side of the membrane (Fig. 2A). The current
work con¢rms the revised topology and implies the existence
of a proton-conducting channel required to convey protons
from the bacterial cytoplasm to the enzyme active site.
2. Materials and methods
2.1. Bacterial strains and plasmids
E. coli Top10 cells (KanR) (Invitrogen) were used in all the experi-
ments. The plasmid pTK1 (Fig. 3), a derivative of pBR322, was the
source of the DNA template for subcloning fragments of the cydAB
operon into the pBAD-TOPO vector (Invitrogen). This was used to
amplify the DNA fragments, and then clone into the XbaI site of
plasmid pWP101 (KanR) [30] to generate the gene fusion constructs
(see Fig. 3).
2.2. Construction of gene fusions
Polymerase chain reaction (PCR) forward primers containing either
the AscI site (for cloning cydA fragments) or the MluI site (for cloning
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Fig. 1. Topological models of the subunits of the cytochrome bd quinol oxidase from E. coli. A: Previously proposed topology of CydA (sub-
unit I) [23,29]. The three residues identi¢ed as heme axial ligands are indicated. The short dark lines indicate the boundaries of the transmem-
brane helices that are proposed by the revised topology, shown in B. B: The revised topology of CydA (subunit I) [3]. The black boxes indicate
the two additional transmembrane helices. C: Topological model of CydB (subunit II) [3]. Arrows show the location of L-lactamase fusion
junctions, numbered as referred to in Table 1.
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cydB fragments) and reverse primers containing the XbaI site (Table
1) were used to amplify portions of the cydA or cydB starting from
the N-termini using Taq polymerase (Invitrogen) (Fig. 3). The mini-
cycler (MJ Research) program was set as follows: 95‡C for 1 min,
55‡C for 1 min, 72‡C for 1 min, number of cycles: 30. PCR products
were cleaned by agarose gel electrophoresis and cloned into the
pBAD-TOPO vector; the constructs were then transformed into
Top10 competent cells. Plasmid DNA from the pBAD-TOPO con-
taining various portions of the cyd operon were digested using AscI/
XbaI restriction enzymes (for cydA fusions) or MluI/XbaI (for cydB
fusions) (Fig. 3). The desired DNA fragments were isolated by aga-
rose gel electrophoresis, extracted using GenElute columns (Sigma) by
centrifuging at 13 000 rpm for 10 min, and then ligated to pWP101
vector, which had been digested with MluI/XbaI restriction enzymes
(Fig. 3). The ligation reactions were used to transform Top10 com-
petent cells and the colonies were selected on Luria^Bertani (LB)
(kanamycin 50 Wg/ml) plates. The fusion junctions of the resulting
plasmid products were con¢rmed by DNA sequencing.
2.3. Plate tests of L-lactamase activity
A single colony of E. coli Top10 harboring the gene fusion plasmid
(pWP101 derivative) was grown in LB-Kan (50 Wg/ml) overnight, then
diluted 106-fold. A 100 Wl aliquot of each dilution was spread on LB
plates containing 50 Wg/ml kanamycin, and concentrations of ampi-
cillin ranging from 5 to 1000 Wg/ml. Colonies were counted after 24 h
of growth at 37‡C. Assays were repeated at least twice for each fusion
with cultures starting from di¡erent individual colonies.
3. Results
In order to distinguish between the two models of CydA
(Fig. 1A, B), ¢ve gene fusions were designed, in which selected
N-terminal fragments from CydA was fused in-frame to L-
lactamase. To con¢rm the methodology, three additional fu-
sions were made to CydB, whose topology is not in question
[23]. The locations of the fusion junctions are shown in Fig. 1,
and the junction sequences are included in Table 1.
Fusions which place the L-lactamase on the periplasmic side
of the membrane should be highly resistant to ampicillin.
However, L-lactamase located in the bacterial cytoplasm will
only have access to ampicillin, if the cells die and lyse. Living
cells in the immediate vicinity of lysed cells will appear resis-
tant to ampicillin, which will be manifested by patches of cells
appearing when the plate is inoculated with a high cell density
[31].
To verify the expression of functional L-lactamase for each
fusion, a high-density inoculum (V106 cells/inoculum) of E.
coli culture was spread on LB plates containing a series of
concentrations of ampicillin (5 to 1000 Wg/ml). Cells express-
ing each of the gene fusions showed growth on plates con-
taining at least 50 Wg/ml of ampicillin. The maximum ampi-
cillin concentration tolerated by each fusion construct is
shown in Fig. 4. Those constructs that result in isolated
patches of colonies [31] are presumed to be fusions where
the L-lactamase is located on the cytoplasmic side of the mem-
brane. The remaining fusions grew as lawns of cells on the
ampicillin plates. All of the constructs exhibited resistance to
ampicillin.
Fig. 2. Schematic models showing the two models in which the loca-
tion of the heme b595/heme d binuclear center is at the periplasmic
(A) or cytoplasmic (B) side of the membrane. Electrons are pre-
sumed to be transferred from heme b558 to the heme b595/heme d
center, and protons used in the chemistry to generate H2O from O2
come from the cytoplasmic side of the membrane. The data in this
paper favor the model shown in A, which requires a proton-con-
ducting channel within the protein.
Table 1
Cyd/L-lactamase fusions
Fusion no. Junction
location
Junction sequencea Predicted activity
from old modelb
Predicted activity
from new modelb
Maximum Amp conc. on
which cells can grow (Wg/ml)
CydA (subunit I)
1 I-K49 CAG ATT TAT AAA TCT AGA CAC CCA + 3 10
2 I-H86 TAC TAT TCC CAC TCT AGA CAC CCA + + 100
3 I-H314 ATG GTG CAG CAT TCT AGA CAC CCA + + 1000
4 I-W451 CGC CAA CCG TGG TCT AGA CAC CCA 3 + 1000
5 I-K505 AGC AGC CTG AAA TCT AGA CAC CCA + 3 10
CydB (subunit II)
6 II-H56 ATT GCA CCA CAC TCT AGA CAC CCA + + 500
7 II-H237 ACA ATG GAC CAT TCT AGA CAC CCA + + 500
8 II-H376 CGT AAC ACC CAC TCT AGA CAC CCA 3 3 10
aThe sequence for L-lactamase is underlined.
bL-Lactamase activity, determined using growth on ampicillin plates.
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LB (Amp) plates were inoculated with a low density of cells
(V200 cells/inoculum) to quantify the ampicillin sensitivity of
each individual fusion construct. This also measures the ac-
cessibility of the L-lactamase moiety to extracellular ampicil-
lin. By using a low-density inoculum, colonies are well sepa-
rated on the plate, so there is no in£uence of lysed cells on the
neighbors since the di¡usion of ampicillin is limited. The
strains expressing gene fusions with the L-lactamase moiety
on the periplasmic surface are able to survive relatively high
levels of ampicillin. The strains with L-lactamase retained in
the cytoplasm are very sensitive to the drug, and 10 Wg/ml of
ampicillin is su⁄cient to kill all cells on the plate. Fig. 5 shows
the maximum ampicillin concentrations allowing growth of
each of the strains. Strains which are resistant to 100 Wg/ml
ampicillin or higher are interpreted as expressing fusions with
the L-lactamase on the periplasmic side of the membrane.
4. Discussion
The results indicate that fusions 2, 3, 4, 6 and 7 are on the
periplasmic side of the membrane and that fusions 1, 5 and 8
are on the cytoplasmic side. The three fusions within CydB
(subunit II) are, as expected, consistent with the previously
published data and with the hydrophobicity models [3,23].
The revised topology of CydA [3] includes two additional
transmembrane spans that were not initially predicted [23].
These are boxed in Fig. 1B. The presence of these transmem-
brane spans [3] predicts that fusions 1 and 5 will be on the
periplasmic side and that fusion 4 will be on the cytoplasmic
side of the membrane, with the reverse true for the initially
proposed topology [23]. As shown in Figs. 4 and 5 and sum-
marized in Table 1, the experimental data are fully consistent
with the new topology. Whereas the previously published gene
fusion studies using alkaline phosphatase and L-galactosidase
had gaps and ambiguities, the current data using L-lactamase
fusions are clear. Note that both the old and the new topol-
ogies place the ligands to heme b558 (His186 and Met393) on
the periplasmic side of the membrane (Fig. 1A, B). The ‘Q
Fig. 3. Schematic showing the plasmids and constructs used to generate the gene fusions between either cydA or cydB and the gene encoding
L-lactamase.
Fig. 4. Maximum ampicillin concentrations tolerated by cells ex-
pressing the cyd/L-lactamase gene fusions, using a high-density cell
inoculum on LB/Amp plates.
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loop’, implicated in quinol binding, has been previously iden-
ti¢ed as being on the periplasmic side of the membrane by
proteolysis and antibody binding studies [32,33]. The data
obtained with fusion 3 are consistent with this periplasmic
location (Table 1).
The importance of the topological picture of CydA is that it
predicts that His19 is located near the periplasmic surface of
the protein. Since His19 has been identi¢ed as the ligand to
the high spin heme b595 component of the oxidase [21,28], this
places the heme b595/heme d active site, where the O2 chem-
istry is catalyzed, near the periplasmic surface of the mem-
brane. Hence, all three hemes are predicted to be near the
periplasmic surface, as depicted in the revised model in Fig.
2A. This suggests heme b558 and the heme b595/heme d com-
plex are likely to be close to each other. Furthermore, the
electrogenic charge transfer across the membrane that is asso-
ciated with turnover of the enzyme [13,18] must primarily be
due to protons crossing the membrane from the cytoplasm to
the active site on the periplasmic side of the membrane. If this
is correct, there must be a proton-conducting channel to facil-
itate proton di¡usion across the membrane (Fig. 2A). There
are conserved acidic residues predicted to be within the mem-
brane domain of CydA [3], which are logical candidates as
residues that may contribute to such a channel. Future studies
will explore this possibility.
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Fig. 5. Maximum ampicillin concentrations tolerated by the cyd/L-
lactamase gene fusions, using a low-density cell inoculum on LB/
Amp plates.
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